Patent ID: 8709454

Claim:
A composition comprising, in a physiologically acceptable medium, at least one phytosphingosine salicylate derivative and at least one lysate of at least one microorganism of the genus Bifidobacterium , wherein said at least one phytosphingosine salicylate derivative is at least one compound of the formula: in which: R represents: a hydrogen atom, a saturated or unsaturated, linear or branched C 1 to C 49 aliphatic radical, optionally substituted with a hydroxyl radical, or a group Y—O(C a H b ) m —, with a being an integer from 7 to 50, b an integer from 10 to 100, m is 0 or 1 and Y represents H or a C 14 -C 22 fatty acid having the formula: —CO—(C x H y Z z )CH 3 , with Z being —OH or an epoxy oxygen, x an integer from 12 to 20, y an integer from 20 to 40, and z is 0 or an integer from 1 to 4; R 1 represents a saturated or unsaturated, linear or branched C 8 to C 28 aliphatic radical, optionally substituted with a hydroxyl radical, and R 2 represents H, a phosphate radical, a sulphate radical or a sugar, wherein the at least one microorganism of the genus Bifidobacterium comprises Bifidobacterium longum , and wherein the phytosphingosine salicylate derivative is present in a proportion of at least 0.0001% expressed as dry weight, relative to the total weight of the composition.